NMRA
NMRA
NASDAQ · Pharmaceuticals

Neumora Therapeutics Inc

Small-Cap Stocks Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$2.51
-0.06 (-2.33%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 12 80%
Hold 2 13%
Sell 1 7%
Price Target
Analyst Price Target +590.8% upside
Low Target $11.85
Average Target $17.34
High Target $21.76
Current Price $2.51
Current
$2.51
Target
$17.34
$11.85 $17.34 avg $21.76
Scenario Analysis
Bear Case
$11.85
372.1%
Low target
Base Case
$17.34
+590.8%
Avg target
Bull Case
$21.76
+766.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.65
-31.2% from high
52-Week Low
$0.61
+310.8% from low
Target vs 52W High
$17.34
+375.1% vs high
Next Earnings Report
Mar 30, 2026 · Before Market Open
3d
until earnings
EPS Est: $-0.33
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%